AdaptHealth (NASDAQ:AHCO) Price Target Raised to $14.00

AdaptHealth (NASDAQ:AHCO) had its price target hoisted by Royal Bank of Canada from $11.00 to $14.00 in a report released on Wednesday,Benzinga reports. The firm currently has an outperform rating on the stock.

A number of other analysts also recently issued reports on AHCO. UBS Group cut their price target on shares of AdaptHealth from $12.00 to $11.00 and set a “buy” rating for the company in a report on Thursday, February 13th. Robert W. Baird decreased their price target on shares of AdaptHealth from $16.00 to $14.00 and set an “outperform” rating for the company in a research report on Wednesday, November 6th. Truist Financial raised their price target on shares of AdaptHealth from $12.00 to $14.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Canaccord Genuity Group decreased their price target on shares of AdaptHealth from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, November 6th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $13.80.

AdaptHealth Stock Up 2.6 %

AHCO stock opened at $11.38 on Wednesday. The company has a market cap of $1.53 billion, a price-to-earnings ratio of -6.90, a PEG ratio of 1.08 and a beta of 1.12. The company has a current ratio of 1.24, a quick ratio of 1.00 and a debt-to-equity ratio of 1.34. AdaptHealth has a 12 month low of $8.35 and a 12 month high of $11.90. The firm has a 50-day moving average of $9.92 and a two-hundred day moving average of $10.23.

Institutional Investors Weigh In On AdaptHealth

Hedge funds and other institutional investors have recently modified their holdings of the company. Assetmark Inc. acquired a new stake in shares of AdaptHealth in the 4th quarter valued at $28,000. Blue Trust Inc. raised its holdings in shares of AdaptHealth by 24.1% in the 4th quarter. Blue Trust Inc. now owns 5,746 shares of the company’s stock valued at $55,000 after purchasing an additional 1,115 shares in the last quarter. Quarry LP raised its holdings in shares of AdaptHealth by 4,596.9% in the 3rd quarter. Quarry LP now owns 5,965 shares of the company’s stock valued at $67,000 after purchasing an additional 5,838 shares in the last quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management raised its holdings in shares of AdaptHealth by 15.4% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 12,663 shares of the company’s stock valued at $121,000 after purchasing an additional 1,690 shares in the last quarter. Finally, CIBC Asset Management Inc acquired a new stake in shares of AdaptHealth in the 3rd quarter valued at $122,000. 82.67% of the stock is currently owned by institutional investors and hedge funds.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.